Frontlight ResearchEarly access
Idiopathic pulmonary fibrosis trials in United States
43 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleDose-Escalation Study of Artesunate Patients With IPF
- Where
- Stanford
- Age
- 40 years and over
- People
- 15
- Run by
- Joseph C. Wu
See details and how to joinNCT05988463 - Phase 2Taking peopleH01 in Adults With Interstitial Lung Disease (The SOLIS Study)
- Where
- Research Triangle Park
- Age
- 18 years to 100 years
- People
- 37
- Run by
- National Institute of Environmental Health Sciences (NIEHS)
See details and how to joinNCT06325696 - Phase 2Taking peopleAdvanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibrosis
- Where
- Boston
- Age
- 18 years to 80 years
- People
- 15
- Run by
- Peter Caravan
See details and how to joinNCT07572383 - Phase 3Taking peopleStudy of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- Where
- Albuquerque, Atlanta, Baltimore, Birmingham, Boston, Charleston, Charlottesville, Chesterfield, Chicago, Cincinnati, Columbia, Columbus, Dallas, Durham, Falls Church, Franklin, Grand Rapids, Greensboro, Greenville, Gulfport, Hershey, Houston, Jacksonville, Kansas City, Knoxville, Lexington, Los Angeles, Louisville, Madison, Maywood, McAllen, McKinney, Milwaukee, Minneapolis, Murray, Nashville, New Hyde Park, New Orleans, Newport Beach, New York, North Dartmouth, Orange, Philadelphia, Phoenix, Redding, Richmond, Rochester, Royal Oak, Sacramento, Salt Lake City, San Antonio, San Diego, Silver Spring, Stanford, St Louis, Stony Brook, Tampa, The Bronx, Toledo, Washington D.C., Weston, Winston-Salem
- Age
- 18 years and over
- People
- 698 worldwide
- Run by
- United Therapeutics
See details and how to joinNCT05943535 · EU 2023-504904-26-00 - No phaseTaking peopleInterstitial Lung Disease Research Unit Biobank
- Where
- Kansas City
- Age
- 18 years and over
- People
- 1,000
- Run by
- University of Kansas Medical Center
See details and how to joinNCT05392881 - No phaseTaking peopleSingle Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary Fibrosis
- Where
- Los Angeles
- Age
- 18 years and over
- People
- 200
- Run by
- University of California, Los Angeles
See details and how to joinNCT06162884 - No phaseTaking peopleA Study of the Natural Progression of Interstitial Lung Disease (ILD)
- Where
- Chicago
- Age
- 18 years and over
- People
- 4,000
- Run by
- University of Chicago
See details and how to joinNCT00470327 - No phaseNot yet taking people in United StatesA Comparison of a Medication Adherence Platform (FORTISKAP™) vs. Usual Care in Subjects on Oral Medications for the Treatment of Interstitial Lung Disease, Sarcoid and Pulmonary Hypertension
- Where
- Norfolk
- Age
- 21 years and over
- People
- 100
- Run by
- Cosmos Rx, Inc
See details and how to joinNCT07613216 - No phaseTaking peopleRheumatoid Arthritis Patients at Risk for Interstitial Lung Disease
- Where
- Aurora
- Age
- 45 years to 90 years
- People
- 750
- Run by
- University of Colorado, Denver
See details and how to joinNCT03297775 - Phase 1Taking peoplePreliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer, and Idiopathic Pulmonary Fibrosis Patients
- Where
- Boston
- Age
- 18 years to 80 years
- People
- 100
- Run by
- Massachusetts General Hospital
See details and how to joinNCT03535545 - Phase 1/2Taking peopleLung and Bone Marrow Transplantation for Lung and Bone Marrow Failure
- Where
- Pittsburgh
- Age
- 18 years to 60 years
- People
- 8
- Run by
- Paul Szabolcs
See details and how to joinNCT03500731 - No phaseTaking peopleMechanisms of Familial Pulmonary Fibrosis
- Where
- Nashville
- Age
- 40 years to 75 years
- People
- 750
- Run by
- Vanderbilt University Medical Center
See details and how to joinNCT03437486 - Phase 2Taking peopleStudy Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- Where
- Birmingham, Celebration, Columbia, Dallas, Los Angeles, McKinney, Oklahoma City, Orlando, Philadelphia, Scottsdale, Winston-Salem
- Age
- 40 years and over
- People
- 40
- Run by
- InSilico Medicine Hong Kong Limited
See details and how to joinNCT05975983 - Phase 2Taking peopleZinc and Nicotinamide Riboside for Idiopathic Pulmonary Fibrosis
- Where
- Los Angeles
- Age
- 50 years and over
- People
- 60
- Run by
- Cedars-Sinai Medical Center
See details and how to joinNCT06567717 - Early phase 1Taking peopleHyperpolarized Xenon-129 MRI in Idiopathic Pulmonary Fibrosis
- Where
- Charlottesville
- Age
- 18 years and over
- People
- 6
- Run by
- University of Virginia
See details and how to joinNCT06853145 - No phaseTaking peopleThe Genetics of Pulmonary Fibrosis
- Where
- Aurora
- Age
- 18 years and over
- People
- 1,000
- Run by
- University of Colorado, Denver
See details and how to joinNCT03478553 - No phaseTaking peopleThe Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis
- Where
- Charlottesville
- Age
- 40 years to 101 years
- People
- 160
- Run by
- University of Virginia
See details and how to joinNCT06323876 - No phaseEnrolling by invitationUniversity of Virginia Natural History Study
- Where
- Charlottesville
- Age
- 18 years and over
- People
- 2,500
- Run by
- University of Virginia
See details and how to joinNCT04896138